Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients.
Nguyen HD, Jouen F, Déchelotte B, Cordel N, Gitiaux C, Bodemer C, Quartier P, Belot A, O'Brien K, Cancemi D, Melki I, Fabien N, Tansley S, Boyer O, Wedderburn LR, Bader-Meunier B; UK JDM Cohort and Biomarker Study. Nguyen HD, et al. Among authors: jouen f. Rheumatology (Oxford). 2024 Oct 1;63(10):e281-e284. doi: 10.1093/rheumatology/keae182. Rheumatology (Oxford). 2024. PMID: 38498839 Free PMC article. No abstract available.
Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study.
Cordel N, Dechelotte B, Jouen F, Lamb JA, Chinoy H, New P, Vencovsky J, Mann H, Galindo-Feria AS, Dani L, Selva-O'Callaghan A, Werth VP, Ravishankar A, Landon-Cardinal O, Tressières B, Boyer O. Cordel N, et al. Among authors: jouen f. Rheumatology (Oxford). 2023 Apr 3;62(4):1711-1715. doi: 10.1093/rheumatology/keac577. Rheumatology (Oxford). 2023. PMID: 36250907
The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.
Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis Study Group. Aussy A, et al. Among authors: jouen f. Arthritis Rheumatol. 2019 Aug;71(8):1360-1370. doi: 10.1002/art.40895. Epub 2019 Jul 8. Arthritis Rheumatol. 2019. PMID: 30896088
French expert opinion for the management of juvenile dermatomyositis.
Bader-Meunier B, Gitiaux C, Belot A, Brochard K, Mouy R, Ponce D, Bughin V, Jouen F, Musset L, Allenbach Y, Hachulla E, Maillard H, Meyer A, Bourrat E, Benveniste O; French Network of rare autoimmune, autoinflammatory diseases FAI2R. Bader-Meunier B, et al. Among authors: jouen f. Arch Pediatr. 2019 Feb;26(2):120-125. doi: 10.1016/j.arcped.2018.12.002. Epub 2019 Jan 10. Arch Pediatr. 2019. PMID: 30638764
Autoimmune Myopathies: Where Do We Stand?
Simon JP, Marie I, Jouen F, Boyer O, Martinet J. Simon JP, et al. Among authors: jouen f. Front Immunol. 2016 Jun 14;7:234. doi: 10.3389/fimmu.2016.00234. eCollection 2016. Front Immunol. 2016. PMID: 27379096 Free PMC article. Review.
Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies.
Julien S, Challier I, Malleter M, Jouen F, Drouot L, Boyer O. Julien S, et al. Among authors: jouen f. Antibodies (Basel). 2024 Feb 7;13(1):12. doi: 10.3390/antib13010012. Antibodies (Basel). 2024. PMID: 38390873 Free PMC article. Review.
Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: Histologic and serologic findings from a new immunoassay.
Hébert V, Duval-Modeste AB, Joly P, Lemée V, Cellier L, Jouen F, Veber B, Drouot L, Boyer O. Hébert V, et al. Among authors: jouen f. J Am Acad Dermatol. 2020 Nov;83(5):1434-1436. doi: 10.1016/j.jaad.2020.07.048. Epub 2020 Jul 16. J Am Acad Dermatol. 2020. PMID: 32682889 Free PMC article. No abstract available.
Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.
Leborgne C, Latournerie V, Boutin S, Desgue D, Quéré A, Pignot E, Collaud F, Charles S, Simon Sola M, Masat E, Jouen F, Boyer O, Masurier C, Mingozzi F, Veron P. Leborgne C, et al. Among authors: jouen f. Cell Immunol. 2019 Aug;342:103780. doi: 10.1016/j.cellimm.2018.03.004. Epub 2018 Mar 16. Cell Immunol. 2019. PMID: 29571923
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.
Fitzpatrick Z, Leborgne C, Barbon E, Masat E, Ronzitti G, van Wittenberghe L, Vignaud A, Collaud F, Charles S, Simon Sola M, Jouen F, Boyer O, Mingozzi F. Fitzpatrick Z, et al. Among authors: jouen f. Mol Ther Methods Clin Dev. 2018 Feb 13;9:119-129. doi: 10.1016/j.omtm.2018.02.003. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2018. PMID: 29766022 Free PMC article.
Immune-mediated necrotizing myopathy.
Bergua C, Chiavelli H, Simon JP, Boyer O, Jouen F, Stenzel W, Martinet J. Bergua C, et al. Among authors: jouen f. Z Rheumatol. 2016 Mar;75(2):151-6. doi: 10.1007/s00393-015-0029-3. Z Rheumatol. 2016. PMID: 26783154 Review.
106 results